SlideShare ist ein Scribd-Unternehmen logo
1 von 13
State Regulations and Guidance GreenPharmEdu.org
State Regulations and Guidance Rules and enforcement vary by state  Examples of innovative state programs: Arizona California Maine Washington Washington D.C.
States Rules and enforcement  The National Alliance for Model State Drug Laws (NAMSDL) The National Alliance for Model State Drug Laws (NAMSDL) is a resource for governors, state legislators, attorneys general, drug and alcohol professionals, community leaders, the recovering community, and others striving for comprehensive and effective state drug and alcohol laws, policies, and programs.  NAMSDL is the successor of the President’s Commission on Model State Drug Laws. Funded by Congressional appropriations since fiscal year 1995, NAMSDL is a 501(c)(3) nonprofit, bipartisan organization. NAMSDL provides the following document that summarizes drug take-back/drop-off programs via state or region: http://www.namsdl.org/documents/PrescriptionDrugTakeBackProgramsforConsumers2010.pdf According to NAMSDL only a handful of states have implemented state-wide programs specifically designed to facilitate the return of unused prescription drugs by consumers
innovative state programs: Arizona The TakeAway program aims to reverse these trends by providing the public with a safe, easy way to properly dispose of unwanted and expired medications. TakeAway uses community pharmacies across the state as take-back sites. Patients can bring unwanted and expired medicines into a participating TakeAway pharmacy. The pharmacist will dispose of the returned medications into a TakeAway system, a waste bin specially designed to safely store discarded pharmaceutical products along with their packaging. Once filled, the TakeAway system is sealed and shipped to a medication disposal facility where the entire TakeAway system and its contents are incinerated. Any pharmaceutical product, prescription or OTC, can be accepted for disposal, EXCLUDING CONTROLLED SUBSTANCES. Medications in any dosage form and any type of packaging are allowed, provided the medications are not controlled substances
innovative state programs: California The Los Angeles County Sheriff’s Department, in conjunction with the Los Angeles County Departments of Public Health and Public Works  present the “Safe Drug Drop-Off” Program.    The program provides an opportunity for residents to safely and anonymously surrender any unused or expired prescriptions, over the counter medications, “SHARPS” (needles), or any other controlled substances.   There will be no questions asked.
innovative state programs: Maine The Safe Medicine Disposal for ME (SMDME) program is a statewide model for the disposal of unused household medications using a mail-back return envelope system.  Established through state legislation and implemented in 2007 with a grant from the U.S. Environmental Protection Agency’s Aging Initiative, the program is authorized to handle both controlled and non-controlled medications.  All drugs collected undergo high-heat incineration, according to the procedure already established for Maine’s law enforcement drug seizures.
innovative state programs: Maine cont. ,[object Object]
Maine Drug Enforcement Agency
Maine Department of Health and Human Services and its Offices of Adult Mental Health Services and Substance Abuse
Maine Benzodiazepine Study Group
Maine Department of Environmental Protection
U.S. Postal Service,
Maine Department of Health

Weitere ähnliche Inhalte

Was ist angesagt?

Drug Approval Bodies in Canada 101: The Elevator Length Pitch
Drug Approval Bodies in Canada 101: The Elevator Length PitchDrug Approval Bodies in Canada 101: The Elevator Length Pitch
Drug Approval Bodies in Canada 101: The Elevator Length PitchCanadian Cancer Survivor Network
 
Drug information by million N
Drug information  by million NDrug information  by million N
Drug information by million Nmillion negasa
 
Principles Of Drug Information 2008
Principles Of Drug Information 2008Principles Of Drug Information 2008
Principles Of Drug Information 2008brosenthal
 
Pharmacy and therapeutic community
Pharmacy and therapeutic communityPharmacy and therapeutic community
Pharmacy and therapeutic communitySHIVANEE VYAS
 
Ashp pharmacy-therapeutics-committee-formulary-system
Ashp pharmacy-therapeutics-committee-formulary-systemAshp pharmacy-therapeutics-committee-formulary-system
Ashp pharmacy-therapeutics-committee-formulary-systemRizal Pharm
 
Sources of drug information
Sources of drug informationSources of drug information
Sources of drug informationSumit Kumar
 
POISON CONTROL CENTRE
POISON CONTROL CENTREPOISON CONTROL CENTRE
POISON CONTROL CENTREMUSHTAQ AHMED
 
Cadth 2015 c6 final- hospital formularies decision-making process es
Cadth 2015 c6   final- hospital formularies decision-making process esCadth 2015 c6   final- hospital formularies decision-making process es
Cadth 2015 c6 final- hospital formularies decision-making process esCADTH Symposium
 
Pharmacy and therapeutics committee
Pharmacy and therapeutics committeePharmacy and therapeutics committee
Pharmacy and therapeutics committeeRavish Yadav
 
Poison information center (Structural Organization and functions)
Poison information center (Structural Organization and functions)Poison information center (Structural Organization and functions)
Poison information center (Structural Organization and functions)Dr. Abhimanyu Prashar
 
Drug Information Resources
Drug Information ResourcesDrug Information Resources
Drug Information ResourcesMary Markland
 
ppt on poison information center organisation and resource
ppt on poison information center organisation and resourceppt on poison information center organisation and resource
ppt on poison information center organisation and resourceAnuragSingh799
 

Was ist angesagt? (20)

Drug Approval Bodies in Canada 101: The Elevator Length Pitch
Drug Approval Bodies in Canada 101: The Elevator Length PitchDrug Approval Bodies in Canada 101: The Elevator Length Pitch
Drug Approval Bodies in Canada 101: The Elevator Length Pitch
 
Drug information center
Drug  information centerDrug  information center
Drug information center
 
Drug information center (dic)
Drug information center (dic)Drug information center (dic)
Drug information center (dic)
 
Drug information by million N
Drug information  by million NDrug information  by million N
Drug information by million N
 
Drug Information Services
Drug Information ServicesDrug Information Services
Drug Information Services
 
Principles Of Drug Information 2008
Principles Of Drug Information 2008Principles Of Drug Information 2008
Principles Of Drug Information 2008
 
Pharmacare 2.0 initiative
Pharmacare 2.0 initiativePharmacare 2.0 initiative
Pharmacare 2.0 initiative
 
Usfda
UsfdaUsfda
Usfda
 
Pharmacy and therapeutic community
Pharmacy and therapeutic communityPharmacy and therapeutic community
Pharmacy and therapeutic community
 
Ashp pharmacy-therapeutics-committee-formulary-system
Ashp pharmacy-therapeutics-committee-formulary-systemAshp pharmacy-therapeutics-committee-formulary-system
Ashp pharmacy-therapeutics-committee-formulary-system
 
Sources of drug information
Sources of drug informationSources of drug information
Sources of drug information
 
POISON CONTROL CENTRE
POISON CONTROL CENTREPOISON CONTROL CENTRE
POISON CONTROL CENTRE
 
Cadth 2015 c6 final- hospital formularies decision-making process es
Cadth 2015 c6   final- hospital formularies decision-making process esCadth 2015 c6   final- hospital formularies decision-making process es
Cadth 2015 c6 final- hospital formularies decision-making process es
 
Pharmacy and therapeutics committee
Pharmacy and therapeutics committeePharmacy and therapeutics committee
Pharmacy and therapeutics committee
 
Clinical Drug Information
Clinical Drug InformationClinical Drug Information
Clinical Drug Information
 
Poison information center (Structural Organization and functions)
Poison information center (Structural Organization and functions)Poison information center (Structural Organization and functions)
Poison information center (Structural Organization and functions)
 
New Directions in Drug Approval in Canada
New Directions in Drug Approval in CanadaNew Directions in Drug Approval in Canada
New Directions in Drug Approval in Canada
 
Drug Information Resources
Drug Information ResourcesDrug Information Resources
Drug Information Resources
 
ppt on poison information center organisation and resource
ppt on poison information center organisation and resourceppt on poison information center organisation and resource
ppt on poison information center organisation and resource
 
NAAZISH AFRAA
NAAZISH AFRAANAAZISH AFRAA
NAAZISH AFRAA
 

Andere mochten auch

Greenhouse Gas Inventories -Scope and Purpose
Greenhouse Gas Inventories -Scope and PurposeGreenhouse Gas Inventories -Scope and Purpose
Greenhouse Gas Inventories -Scope and PurposetheREDDdesk
 
Lyfe Cycle Analyses: Concepts and Case Study - ERM
Lyfe Cycle Analyses: Concepts and Case Study - ERMLyfe Cycle Analyses: Concepts and Case Study - ERM
Lyfe Cycle Analyses: Concepts and Case Study - ERMRevista H&C
 
Lci deca how to get involved in your local diabetes camp
Lci deca how to get involved in your local diabetes campLci deca how to get involved in your local diabetes camp
Lci deca how to get involved in your local diabetes campVanessa Avila
 
Life Cycle Analysis: Car sharing
Life Cycle Analysis: Car sharing Life Cycle Analysis: Car sharing
Life Cycle Analysis: Car sharing MDLewis
 
Managing the research life cycle
Managing the research life cycleManaging the research life cycle
Managing the research life cycleSherry Lake
 
SRA 2012 - Towards a Life Cycle Aware Chemical Risk Analysis
SRA 2012 - Towards a Life Cycle Aware Chemical Risk AnalysisSRA 2012 - Towards a Life Cycle Aware Chemical Risk Analysis
SRA 2012 - Towards a Life Cycle Aware Chemical Risk AnalysisBrandon Kuczenski
 
Navigating the Marine Geophysical Data Life Cycle
Navigating the Marine Geophysical Data Life CycleNavigating the Marine Geophysical Data Life Cycle
Navigating the Marine Geophysical Data Life CycleVicki Ferrini
 
life cycle assessment paper
life cycle assessment paperlife cycle assessment paper
life cycle assessment paperdakamns
 
Ghgp product life_cycle_standard
Ghgp product life_cycle_standardGhgp product life_cycle_standard
Ghgp product life_cycle_standardgreennet-beta
 
6: Energy Management in Water Supply Systems - Life-Cycle Cost Analysis
6: Energy Management in Water Supply Systems - Life-Cycle Cost Analysis6: Energy Management in Water Supply Systems - Life-Cycle Cost Analysis
6: Energy Management in Water Supply Systems - Life-Cycle Cost AnalysisAlliance To Save Energy
 
Ian Smith 2013 Honeywell Project Overview
Ian Smith 2013 Honeywell Project OverviewIan Smith 2013 Honeywell Project Overview
Ian Smith 2013 Honeywell Project OverviewIan Smith
 
CIB Conference Paper 2013 - Life cycle energy analysis of residential buildin...
CIB Conference Paper 2013 - Life cycle energy analysis of residential buildin...CIB Conference Paper 2013 - Life cycle energy analysis of residential buildin...
CIB Conference Paper 2013 - Life cycle energy analysis of residential buildin...Melissa Gaspari
 
Legislative intent behind environmental law
Legislative intent behind environmental lawLegislative intent behind environmental law
Legislative intent behind environmental lawAkash Patel
 
Ecological economics. Farber & bradley
Ecological economics. Farber & bradleyEcological economics. Farber & bradley
Ecological economics. Farber & bradleyIntrosust
 
Integration of Life Cycle Thinking within Research & Development
Integration of Life Cycle Thinking within Research & DevelopmentIntegration of Life Cycle Thinking within Research & Development
Integration of Life Cycle Thinking within Research & DevelopmentLocus Research
 
Introduction to ISO29110
Introduction to ISO29110Introduction to ISO29110
Introduction to ISO29110Krit Kamtuo
 
Rubber and Plastics Industry Webinar: 21-Sep-2011
Rubber and Plastics Industry Webinar: 21-Sep-2011Rubber and Plastics Industry Webinar: 21-Sep-2011
Rubber and Plastics Industry Webinar: 21-Sep-2011BusinessVibes_Network
 
Wood and Sustainable Building - Lunch & Learn
Wood and Sustainable Building - Lunch & LearnWood and Sustainable Building - Lunch & Learn
Wood and Sustainable Building - Lunch & LearnFWPA
 
Lecture:Organic/Bio waste Life Cycle Assessment case studies
Lecture:Organic/Bio waste Life Cycle Assessment case studiesLecture:Organic/Bio waste Life Cycle Assessment case studies
Lecture:Organic/Bio waste Life Cycle Assessment case studiesDaniel Sandars
 

Andere mochten auch (20)

Greenhouse Gas Inventories -Scope and Purpose
Greenhouse Gas Inventories -Scope and PurposeGreenhouse Gas Inventories -Scope and Purpose
Greenhouse Gas Inventories -Scope and Purpose
 
Lyfe Cycle Analyses: Concepts and Case Study - ERM
Lyfe Cycle Analyses: Concepts and Case Study - ERMLyfe Cycle Analyses: Concepts and Case Study - ERM
Lyfe Cycle Analyses: Concepts and Case Study - ERM
 
Lci deca how to get involved in your local diabetes camp
Lci deca how to get involved in your local diabetes campLci deca how to get involved in your local diabetes camp
Lci deca how to get involved in your local diabetes camp
 
Life Cycle Analysis: Car sharing
Life Cycle Analysis: Car sharing Life Cycle Analysis: Car sharing
Life Cycle Analysis: Car sharing
 
Managing the research life cycle
Managing the research life cycleManaging the research life cycle
Managing the research life cycle
 
SRA 2012 - Towards a Life Cycle Aware Chemical Risk Analysis
SRA 2012 - Towards a Life Cycle Aware Chemical Risk AnalysisSRA 2012 - Towards a Life Cycle Aware Chemical Risk Analysis
SRA 2012 - Towards a Life Cycle Aware Chemical Risk Analysis
 
Navigating the Marine Geophysical Data Life Cycle
Navigating the Marine Geophysical Data Life CycleNavigating the Marine Geophysical Data Life Cycle
Navigating the Marine Geophysical Data Life Cycle
 
life cycle assessment paper
life cycle assessment paperlife cycle assessment paper
life cycle assessment paper
 
Ghgp product life_cycle_standard
Ghgp product life_cycle_standardGhgp product life_cycle_standard
Ghgp product life_cycle_standard
 
6: Energy Management in Water Supply Systems - Life-Cycle Cost Analysis
6: Energy Management in Water Supply Systems - Life-Cycle Cost Analysis6: Energy Management in Water Supply Systems - Life-Cycle Cost Analysis
6: Energy Management in Water Supply Systems - Life-Cycle Cost Analysis
 
Ian Smith 2013 Honeywell Project Overview
Ian Smith 2013 Honeywell Project OverviewIan Smith 2013 Honeywell Project Overview
Ian Smith 2013 Honeywell Project Overview
 
CIB Conference Paper 2013 - Life cycle energy analysis of residential buildin...
CIB Conference Paper 2013 - Life cycle energy analysis of residential buildin...CIB Conference Paper 2013 - Life cycle energy analysis of residential buildin...
CIB Conference Paper 2013 - Life cycle energy analysis of residential buildin...
 
Legislative intent behind environmental law
Legislative intent behind environmental lawLegislative intent behind environmental law
Legislative intent behind environmental law
 
Ecological economics. Farber & bradley
Ecological economics. Farber & bradleyEcological economics. Farber & bradley
Ecological economics. Farber & bradley
 
Integration of Life Cycle Thinking within Research & Development
Integration of Life Cycle Thinking within Research & DevelopmentIntegration of Life Cycle Thinking within Research & Development
Integration of Life Cycle Thinking within Research & Development
 
Introduction to ISO29110
Introduction to ISO29110Introduction to ISO29110
Introduction to ISO29110
 
Rubber and Plastics Industry Webinar: 21-Sep-2011
Rubber and Plastics Industry Webinar: 21-Sep-2011Rubber and Plastics Industry Webinar: 21-Sep-2011
Rubber and Plastics Industry Webinar: 21-Sep-2011
 
Comparison of glass and plastic intravenous fluid bottles in hospitals
Comparison of glass and plastic intravenous fluid bottles in hospitalsComparison of glass and plastic intravenous fluid bottles in hospitals
Comparison of glass and plastic intravenous fluid bottles in hospitals
 
Wood and Sustainable Building - Lunch & Learn
Wood and Sustainable Building - Lunch & LearnWood and Sustainable Building - Lunch & Learn
Wood and Sustainable Building - Lunch & Learn
 
Lecture:Organic/Bio waste Life Cycle Assessment case studies
Lecture:Organic/Bio waste Life Cycle Assessment case studiesLecture:Organic/Bio waste Life Cycle Assessment case studies
Lecture:Organic/Bio waste Life Cycle Assessment case studies
 

Ähnlich wie 5.5. State Regulations and Guidance (Batz)

Proper Disposal of Unwanted Medicines with a Focus on the Aging. Source:U.S. ...
Proper Disposal of Unwanted Medicines with a Focus on the Aging. Source:U.S. ...Proper Disposal of Unwanted Medicines with a Focus on the Aging. Source:U.S. ...
Proper Disposal of Unwanted Medicines with a Focus on the Aging. Source:U.S. ...SerPIE Repository
 
State profile -_new_york_0
State profile -_new_york_0State profile -_new_york_0
State profile -_new_york_0satoriwatersfl
 
VFCC_-_A_Medical_Cannabis_Clinical_Model___Nov_2014_(rs)-5 copy
VFCC_-_A_Medical_Cannabis_Clinical_Model___Nov_2014_(rs)-5 copyVFCC_-_A_Medical_Cannabis_Clinical_Model___Nov_2014_(rs)-5 copy
VFCC_-_A_Medical_Cannabis_Clinical_Model___Nov_2014_(rs)-5 copyMatthew Boyle
 
8 pharmacy track pharmacists working with local coalitions and pdm ps
8 pharmacy track pharmacists working with local coalitions and pdm ps8 pharmacy track pharmacists working with local coalitions and pdm ps
8 pharmacy track pharmacists working with local coalitions and pdm psOPUNITE
 
The Problem of Unwanted Medicines: (Source: Susan E. Boehme & Elizabeth H. Ma...
The Problem of Unwanted Medicines: (Source: Susan E. Boehme & Elizabeth H. Ma...The Problem of Unwanted Medicines: (Source: Susan E. Boehme & Elizabeth H. Ma...
The Problem of Unwanted Medicines: (Source: Susan E. Boehme & Elizabeth H. Ma...SerPIE Repository
 
Rx15 pharma wed_300_1_egan-gregory_2gray
Rx15 pharma wed_300_1_egan-gregory_2grayRx15 pharma wed_300_1_egan-gregory_2gray
Rx15 pharma wed_300_1_egan-gregory_2grayOPUNITE
 
6 5 10 Drug Drop, Inc. Business Plan
6 5 10 Drug Drop, Inc. Business Plan6 5 10 Drug Drop, Inc. Business Plan
6 5 10 Drug Drop, Inc. Business PlanKim Fithian
 
Hazardous Chemicals in Health Care
Hazardous Chemicals in Health CareHazardous Chemicals in Health Care
Hazardous Chemicals in Health Carev2zq
 
Tuesday astho
Tuesday asthoTuesday astho
Tuesday asthoOPUNITE
 
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbins
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbinsRx16 adv tues_200_1_wright_2orr_3landen_4hartstebbins
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbinsOPUNITE
 
Jasper Social Touching Class Data SP18 (1).savstatistics.jnl.docx
Jasper Social Touching Class Data SP18 (1).savstatistics.jnl.docxJasper Social Touching Class Data SP18 (1).savstatistics.jnl.docx
Jasper Social Touching Class Data SP18 (1).savstatistics.jnl.docxchristiandean12115
 
Prescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP)Prescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP)Katharine Bovenkerk
 
Rx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4nader
Rx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4naderRx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4nader
Rx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4naderOPUNITE
 
Rx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyRx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyOPUNITE
 

Ähnlich wie 5.5. State Regulations and Guidance (Batz) (20)

Proper Disposal of Unwanted Medicines with a Focus on the Aging. Source:U.S. ...
Proper Disposal of Unwanted Medicines with a Focus on the Aging. Source:U.S. ...Proper Disposal of Unwanted Medicines with a Focus on the Aging. Source:U.S. ...
Proper Disposal of Unwanted Medicines with a Focus on the Aging. Source:U.S. ...
 
ENVS capstone poster
ENVS capstone posterENVS capstone poster
ENVS capstone poster
 
State profile -_new_york_0
State profile -_new_york_0State profile -_new_york_0
State profile -_new_york_0
 
VFCC_-_A_Medical_Cannabis_Clinical_Model___Nov_2014_(rs)-5 copy
VFCC_-_A_Medical_Cannabis_Clinical_Model___Nov_2014_(rs)-5 copyVFCC_-_A_Medical_Cannabis_Clinical_Model___Nov_2014_(rs)-5 copy
VFCC_-_A_Medical_Cannabis_Clinical_Model___Nov_2014_(rs)-5 copy
 
8 pharmacy track pharmacists working with local coalitions and pdm ps
8 pharmacy track pharmacists working with local coalitions and pdm ps8 pharmacy track pharmacists working with local coalitions and pdm ps
8 pharmacy track pharmacists working with local coalitions and pdm ps
 
The Problem of Unwanted Medicines: (Source: Susan E. Boehme & Elizabeth H. Ma...
The Problem of Unwanted Medicines: (Source: Susan E. Boehme & Elizabeth H. Ma...The Problem of Unwanted Medicines: (Source: Susan E. Boehme & Elizabeth H. Ma...
The Problem of Unwanted Medicines: (Source: Susan E. Boehme & Elizabeth H. Ma...
 
6 pcpsa bc vanasse
6 pcpsa bc vanasse6 pcpsa bc vanasse
6 pcpsa bc vanasse
 
Rx15 pharma wed_300_1_egan-gregory_2gray
Rx15 pharma wed_300_1_egan-gregory_2grayRx15 pharma wed_300_1_egan-gregory_2gray
Rx15 pharma wed_300_1_egan-gregory_2gray
 
6 5 10 Drug Drop, Inc. Business Plan
6 5 10 Drug Drop, Inc. Business Plan6 5 10 Drug Drop, Inc. Business Plan
6 5 10 Drug Drop, Inc. Business Plan
 
Addco
AddcoAddco
Addco
 
Hazardous Chemicals in Health Care
Hazardous Chemicals in Health CareHazardous Chemicals in Health Care
Hazardous Chemicals in Health Care
 
Tuesday astho
Tuesday asthoTuesday astho
Tuesday astho
 
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbins
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbinsRx16 adv tues_200_1_wright_2orr_3landen_4hartstebbins
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbins
 
Clinical Research Glossary
Clinical Research GlossaryClinical Research Glossary
Clinical Research Glossary
 
Jasper Social Touching Class Data SP18 (1).savstatistics.jnl.docx
Jasper Social Touching Class Data SP18 (1).savstatistics.jnl.docxJasper Social Touching Class Data SP18 (1).savstatistics.jnl.docx
Jasper Social Touching Class Data SP18 (1).savstatistics.jnl.docx
 
Prescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP)Prescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP)
 
Rx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4nader
Rx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4naderRx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4nader
Rx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4nader
 
ERs Face the Problem of Multiple Drugs in Overdose Patients
ERs Face the Problem of Multiple Drugs in Overdose PatientsERs Face the Problem of Multiple Drugs in Overdose Patients
ERs Face the Problem of Multiple Drugs in Overdose Patients
 
Pharmacare - Caveat Emptor (Let the Buyer Beware)
Pharmacare - Caveat Emptor (Let the Buyer Beware)Pharmacare - Caveat Emptor (Let the Buyer Beware)
Pharmacare - Caveat Emptor (Let the Buyer Beware)
 
Rx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyRx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashley
 

Mehr von Teleosis Institute

3.4. What is Accumulating & How Do We Know? (Kreisberg)
3.4. What is Accumulating & How Do We Know? (Kreisberg)3.4. What is Accumulating & How Do We Know? (Kreisberg)
3.4. What is Accumulating & How Do We Know? (Kreisberg)Teleosis Institute
 
3.3. The Reality of Non-Compliance
3.3. The Reality of Non-Compliance3.3. The Reality of Non-Compliance
3.3. The Reality of Non-ComplianceTeleosis Institute
 
3.2. Life Cycle Dynamics (Kreisberg)
3.2. Life Cycle Dynamics (Kreisberg)3.2. Life Cycle Dynamics (Kreisberg)
3.2. Life Cycle Dynamics (Kreisberg)Teleosis Institute
 
3.6. Reducing Pharmaceutical Waste in Clinical Care (Kreisberg)
3.6. Reducing Pharmaceutical Waste in Clinical Care (Kreisberg)3.6. Reducing Pharmaceutical Waste in Clinical Care (Kreisberg)
3.6. Reducing Pharmaceutical Waste in Clinical Care (Kreisberg)Teleosis Institute
 
2.3. Evidence for Ecotoxicity (Ruhoy)
2.3. Evidence for Ecotoxicity (Ruhoy)2.3. Evidence for Ecotoxicity (Ruhoy)
2.3. Evidence for Ecotoxicity (Ruhoy)Teleosis Institute
 
5.4. Federal Regulations (Batz)
5.4. Federal Regulations (Batz)5.4. Federal Regulations (Batz)
5.4. Federal Regulations (Batz)Teleosis Institute
 
5.3. Methods of Disposal (Batz)
5.3. Methods of Disposal (Batz)5.3. Methods of Disposal (Batz)
5.3. Methods of Disposal (Batz)Teleosis Institute
 
5.2. Reason for Concern (Batz)
5.2. Reason for Concern (Batz)5.2. Reason for Concern (Batz)
5.2. Reason for Concern (Batz)Teleosis Institute
 
2.6. Reducing Unused Pharmaceuticals: Conclusion (Ruhoy)
2.6. Reducing Unused Pharmaceuticals: Conclusion (Ruhoy)2.6. Reducing Unused Pharmaceuticals: Conclusion (Ruhoy)
2.6. Reducing Unused Pharmaceuticals: Conclusion (Ruhoy)Teleosis Institute
 
2.4. Environmental Impact of Disposal (Ruhoy)
2.4. Environmental Impact of Disposal (Ruhoy)2.4. Environmental Impact of Disposal (Ruhoy)
2.4. Environmental Impact of Disposal (Ruhoy)Teleosis Institute
 
2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)
2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)
2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)Teleosis Institute
 
2.1. Pharmaceutical in the Environment: An Evidence-based Review: Introductio...
2.1. Pharmaceutical in the Environment: An Evidence-based Review: Introductio...2.1. Pharmaceutical in the Environment: An Evidence-based Review: Introductio...
2.1. Pharmaceutical in the Environment: An Evidence-based Review: Introductio...Teleosis Institute
 
2.5. PharmEcoVigilance (Ruhoy)
2.5. PharmEcoVigilance (Ruhoy)2.5. PharmEcoVigilance (Ruhoy)
2.5. PharmEcoVigilance (Ruhoy)Teleosis Institute
 

Mehr von Teleosis Institute (16)

3.4. What is Accumulating & How Do We Know? (Kreisberg)
3.4. What is Accumulating & How Do We Know? (Kreisberg)3.4. What is Accumulating & How Do We Know? (Kreisberg)
3.4. What is Accumulating & How Do We Know? (Kreisberg)
 
3.3. The Reality of Non-Compliance
3.3. The Reality of Non-Compliance3.3. The Reality of Non-Compliance
3.3. The Reality of Non-Compliance
 
3.2. Life Cycle Dynamics (Kreisberg)
3.2. Life Cycle Dynamics (Kreisberg)3.2. Life Cycle Dynamics (Kreisberg)
3.2. Life Cycle Dynamics (Kreisberg)
 
3.1. Introduction (Kreisberg)
3.1. Introduction (Kreisberg)3.1. Introduction (Kreisberg)
3.1. Introduction (Kreisberg)
 
3.6. Reducing Pharmaceutical Waste in Clinical Care (Kreisberg)
3.6. Reducing Pharmaceutical Waste in Clinical Care (Kreisberg)3.6. Reducing Pharmaceutical Waste in Clinical Care (Kreisberg)
3.6. Reducing Pharmaceutical Waste in Clinical Care (Kreisberg)
 
2.3. Evidence for Ecotoxicity (Ruhoy)
2.3. Evidence for Ecotoxicity (Ruhoy)2.3. Evidence for Ecotoxicity (Ruhoy)
2.3. Evidence for Ecotoxicity (Ruhoy)
 
5.4. Federal Regulations (Batz)
5.4. Federal Regulations (Batz)5.4. Federal Regulations (Batz)
5.4. Federal Regulations (Batz)
 
5.3. Methods of Disposal (Batz)
5.3. Methods of Disposal (Batz)5.3. Methods of Disposal (Batz)
5.3. Methods of Disposal (Batz)
 
5.2. Reason for Concern (Batz)
5.2. Reason for Concern (Batz)5.2. Reason for Concern (Batz)
5.2. Reason for Concern (Batz)
 
5.6. Conclusion (Batz)
5.6. Conclusion (Batz)5.6. Conclusion (Batz)
5.6. Conclusion (Batz)
 
5.1. Introduction (Batz)
5.1. Introduction (Batz)5.1. Introduction (Batz)
5.1. Introduction (Batz)
 
2.6. Reducing Unused Pharmaceuticals: Conclusion (Ruhoy)
2.6. Reducing Unused Pharmaceuticals: Conclusion (Ruhoy)2.6. Reducing Unused Pharmaceuticals: Conclusion (Ruhoy)
2.6. Reducing Unused Pharmaceuticals: Conclusion (Ruhoy)
 
2.4. Environmental Impact of Disposal (Ruhoy)
2.4. Environmental Impact of Disposal (Ruhoy)2.4. Environmental Impact of Disposal (Ruhoy)
2.4. Environmental Impact of Disposal (Ruhoy)
 
2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)
2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)
2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)
 
2.1. Pharmaceutical in the Environment: An Evidence-based Review: Introductio...
2.1. Pharmaceutical in the Environment: An Evidence-based Review: Introductio...2.1. Pharmaceutical in the Environment: An Evidence-based Review: Introductio...
2.1. Pharmaceutical in the Environment: An Evidence-based Review: Introductio...
 
2.5. PharmEcoVigilance (Ruhoy)
2.5. PharmEcoVigilance (Ruhoy)2.5. PharmEcoVigilance (Ruhoy)
2.5. PharmEcoVigilance (Ruhoy)
 

5.5. State Regulations and Guidance (Batz)

  • 1. State Regulations and Guidance GreenPharmEdu.org
  • 2. State Regulations and Guidance Rules and enforcement vary by state  Examples of innovative state programs: Arizona California Maine Washington Washington D.C.
  • 3. States Rules and enforcement The National Alliance for Model State Drug Laws (NAMSDL) The National Alliance for Model State Drug Laws (NAMSDL) is a resource for governors, state legislators, attorneys general, drug and alcohol professionals, community leaders, the recovering community, and others striving for comprehensive and effective state drug and alcohol laws, policies, and programs. NAMSDL is the successor of the President’s Commission on Model State Drug Laws. Funded by Congressional appropriations since fiscal year 1995, NAMSDL is a 501(c)(3) nonprofit, bipartisan organization. NAMSDL provides the following document that summarizes drug take-back/drop-off programs via state or region: http://www.namsdl.org/documents/PrescriptionDrugTakeBackProgramsforConsumers2010.pdf According to NAMSDL only a handful of states have implemented state-wide programs specifically designed to facilitate the return of unused prescription drugs by consumers
  • 4. innovative state programs: Arizona The TakeAway program aims to reverse these trends by providing the public with a safe, easy way to properly dispose of unwanted and expired medications. TakeAway uses community pharmacies across the state as take-back sites. Patients can bring unwanted and expired medicines into a participating TakeAway pharmacy. The pharmacist will dispose of the returned medications into a TakeAway system, a waste bin specially designed to safely store discarded pharmaceutical products along with their packaging. Once filled, the TakeAway system is sealed and shipped to a medication disposal facility where the entire TakeAway system and its contents are incinerated. Any pharmaceutical product, prescription or OTC, can be accepted for disposal, EXCLUDING CONTROLLED SUBSTANCES. Medications in any dosage form and any type of packaging are allowed, provided the medications are not controlled substances
  • 5. innovative state programs: California The Los Angeles County Sheriff’s Department, in conjunction with the Los Angeles County Departments of Public Health and Public Works present the “Safe Drug Drop-Off” Program. The program provides an opportunity for residents to safely and anonymously surrender any unused or expired prescriptions, over the counter medications, “SHARPS” (needles), or any other controlled substances. There will be no questions asked.
  • 6. innovative state programs: Maine The Safe Medicine Disposal for ME (SMDME) program is a statewide model for the disposal of unused household medications using a mail-back return envelope system. Established through state legislation and implemented in 2007 with a grant from the U.S. Environmental Protection Agency’s Aging Initiative, the program is authorized to handle both controlled and non-controlled medications. All drugs collected undergo high-heat incineration, according to the procedure already established for Maine’s law enforcement drug seizures.
  • 7.
  • 9. Maine Department of Health and Human Services and its Offices of Adult Mental Health Services and Substance Abuse
  • 11. Maine Department of Environmental Protection
  • 14. Maine Office of the Attorney General
  • 16.
  • 17. innovative state programs: Maine cont. During the cataloging, drugs were sorted according to whether they were controlled drugs or not and further into controlled hazardous or controlled non-hazardous categories. This sorting method facilitated appropriate disposal and therefore helped control disposal costs. The mail-back program, during its first two phases of EPA-funded operation, has disposed of more than 2,300 lbs of drugs, representing 3,926 returned envelopes. A total of 9,400 enveloped were distributed during this period representing a 42% envelope utilization and return rate. There have been eight cataloging events during this period.
  • 18. innovative state programs: Washington The state of Washington has implemented a program to enable people to drop off their unwanted medications for disposal at participating pharmacies and police stations. The website lists, via county, what pharmacies and police stations are accepting these items.  Pharmacies in this program cannot accept controlled substances at this time and refer to participating police stations. The website advises the public on who to contact regarding disposal of hazardous wastes, such as needles and sharps.
  • 19. innovative state programs: Washington D.C. This pilot program is limited to an estimated 780,000 veterans living in Baltimore, Washington, DC, and West Virginia. Veterans mail back outdated, unwanted medicine. Federally approved facilities safely destroy the medicine, insuring that prescriptions don’t end up in municipal refuse, soil or ground water. Veterans will be able to safely dispose of expired and unused prescriptions and help the environment at the same under a program offered by the U.S. Postal Service and U.S. Department of Veterans Affairs (VA).
  • 20. innovative state programs: Washington D.C. cont. Veterans receive specially designed, postage-paid envelopes and instructions with their prescription fulfillment. Expired and unused pharmaceuticals placed in the special packaging can be dropped in familiar blue USPS collection boxes or at Post Offices. The envelopes are delivered to facilities regulated and approved by the Environmental Protection Agency (EPA) and Drug Enforcement Agency (DEA). Pharmaceuticals from this and other similar mail-back initiatives are destroyed in accordance with EPA and DEA standards, including cataloguing and use of incineration, chemical or thermal processes.
  • 21. innovative state programs These are just a few examples of state take back programs. For further examples please see: http://www.takebacknetwork.com/local_efforts.html http://www.takebacknetwork.com/resources.html